CoChat

Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer

Open access
Troiani, Martina, Colucci, Manuel, D’Ambrosio, Mariantonietta, Guccini, Ilaria, Pasquini, Emiliano, Varesi, Angelica, Valdata, Aurora, Mosole, Simone, Revandkar, Ajinkya, Attanasio, Giuseppe, Rinaldi, Andrea, Rinaldi, Anna, Bolis, Marco, Cippà, Pietro, Alimonti, Andrea · 2022 · Nature Communications
Cited by 123

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Cells subjected to treatment with anti-cancer therapies can evade apoptosis through cellular senescence. Persistent senescent tumor cells remain metabolically active, possess a secretory phenotype, and can promote tumor proliferation and metastatic dissemination. Removal of senescent tumor cells (senolytic therapy) has therefore emerged as a promising therapeutic strategy. Here, using single-cell RNA-sequencing, we find that senescent tumor cells rely on the anti-apoptotic gene Mcl-1 for their survival. Mcl-1 is upregulated in senescent tumor cells, including cells expressing low levels of Bcl-2, an established target for senolytic therapy. While treatment with the Bcl-2 inhibitor Navitoclax results in the reduction of metastases in tumor bearing mice, treatment with the Mcl-1 inhibitor S63845 leads to complete elimination of senescent tumor cells and metastases. These findings provide insights on the mechanism by which senescent tumor cells survive and reveal a vulnerability that can be exploited for cancer therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-29824-1

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 39

  1. Hernandez-Segura, A., Nehme, J. & Demaria, M. Hallmarks of Cellular Senescence. Trends Cell Biol 28, 436–453 (2018). · DOI · Paper page
  2. Scudellari, M. To stay young, kill zombie cells. Nature 550, 448–450 (2017). · DOI
  3. Lau, L. & David, G. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype. Exp. Opin. Ther. Targets 23, 1041–1051 (2019). · DOI · Paper page
  4. Saleh, T. et al. Tumor cell escape from therapy-induced senescence. Biochem. Pharmacol. 162, 202–212 (2019). · DOI · Paper page
  5. Serrano, M. & Barzilai, N. Targeting senescence. Nat. Med. 24, 1092–1094 (2018). · DOI
  6. Bollard, J. et al. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut 66, 1286–1296 (2017). · DOI · Paper page
  7. Yuan, L., Alexander, P. B. & Wang, X.-F. Cellular senescence: from anti-cancer weapon to anti-aging target. Sci. China Life Sci. 63, 332–342 (2020). · DOI
  8. Pandey, K. et al. Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence. Cancers 12, 3566 (2020). · DOI · Paper page
  9. Gao, S. Data Analysis in Single-Cell Transcriptome Sequencing. Methods Mol. Biol. 1754, 311–326 (2018). · DOI
  10. Chen, S. et al. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23, 87–98 (2021). · DOI · Paper page
  11. Lee, Y.-R., Chen, M. & Pandolfi, P. P. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat. Rev. Mol. Cell Biol. 19, 547–562 (2018). · DOI · Paper page
  12. Lee, S. & Schmitt, C. A. The dynamic nature of senescence in cancer. Nat. Cell Biol. 21, 94–101 (2019). · DOI · Paper page
  13. Shyh-Chang, N., Daley, G. Q. & Cantley, L. C. Stem cell metabolism in tissue development and aging. Development 140, 2535–2547 (2013). · DOI · Paper page
  14. Mongi-Bragato, B. et al. Pivotal role of NF-κB in cellular senescence of experimental pituitary tumours. J. Endocrinol. 245, 179–191 (2020). · DOI
  15. Lesina, M. et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J. Clin. Investig. 126, 2919–2932 (2016). · DOI · Paper page
  16. Kiselev, V. Y., Yiu, A. & Hemberg, M. scmap: projection of single-cell RNA-seq data across data sets. Nat. Methods 15, 359–362 (2018). · doi:10.1038/nmeth.4644
  17. Yamane, M. et al. Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans. FASEB J. 34, 10778–10800 (2020). · DOI
  18. Mavrogonatou, E., Konstantinou, A. & Kletsas, D. Long-term exposure to TNF-α leads human skin fibroblasts to a p38 MAPK- and ROS-mediated premature senescence. Biogerontology 19, 237–249 (2018). · DOI
  19. Rovillain, E. et al. Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356–2366 (2011). · DOI · Paper page
  20. Liu, S. et al. The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro. Aging Cell 10, 661–674 (2011). · DOI · Paper page
  21. Oka, T. et al. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells. J. Immunol. 198, 3897–3908 (2017). · DOI
  22. Zhang, H. et al. CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer. Oncogene 36, 2095–2104 (2017). · DOI · Paper page
  23. Glaser, S. P. et al. Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Genes Dev. 26, 120–125 (2012). · DOI · Paper page
  24. Li, Z., He, S. & Look, A. T. The MCL1-specific inhibitor S63845 acts synergistically with venetoclax/ABT-199 to induce apoptosis in T-cell acute lymphoblastic leukemia cells. Leukemia 33, 262–266 (2019). · DOI
  25. Tron, A. E. et al. Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia. Nat. Commun. 9, 5341 (2018).
  26. Abulwerdi, F. et al. A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo. Mol. Cancer Ther. 13, 565–575 (2014). · DOI · Paper page
  27. Calcinotto, A. & Andrea, A. Aging tumour cells to cure cancer: “pro-senescence” therapy for cancer. Swiss Med. Wkly 147, w14367 (2017). 2017. · DOI
  28. Wang, H., Guo, M., Wei, H. & Chen, Y. Targeting MCL-1 in cancer: current status and perspectives. J. Hematol. Oncol. 14, 67 (2021). · DOI · Paper page
  29. Shahbandi, A. et al. BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer. Cell Death Differ. 27, 3097–3116 (2020). · DOI
  30. Cho, H. et al. RapidCaP, a Novel GEM Model for Metastatic Prostate Cancer Analysis and Therapy, Reveals Myc as a Driver of Pten -Mutant Metastasis. Cancer Discov. 4, 318–333 (2014). · DOI
  31. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013). · DOI · Paper page
  32. Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018). · DOI · Paper page
  33. Stuart, T. et al. Comprehensive Integration of Single-. Cell Data. Cell 177, 1888–1902.e1821 (2019).
  34. Karthaus, W. R. et al. Regenerative potential of prostate luminal cells revealed by single-cell analysis. Science 368, 497–505 (2020). · DOI · Paper page
  35. Kanehisa, M. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000). · DOI · Paper page
  36. Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545–D551 (2021). · DOI · Paper page
  37. Jassal, B. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 48, D498–D503 (2020).
  38. Kelder, T. et al. WikiPathways: building research communities on biological pathways. Nucleic Acids Res. 40, D1301–1307 (2012). · DOI · Paper page
  39. Vizioli, M. G. et al. Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence. Genes Dev. 34, 428–445 (2020). · DOI · Paper page

Cited by

See all 123

Metadata

Authors
Troiani, M., Colucci, M., D’Ambrosio, M., Guccini, I., Pasquini, E., Varesi, A., Valdata, A., Mosole, S., Revandkar, A., Attanasio, G., Rinaldi, A., Rinaldi, A., Bolis, M., Cippà, P., & Alimonti, A.
Venue
Nature Communications
Published
2022-04-21
Volume
13
Issue
1
Pages
2177-2177
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4224233282
Cited by
123
References
51
FWCI
13.09
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer. https://app.cochat.ai/papers/10.1038/s41467-022-29824-1
The paper
Troiani, M., Colucci, M., D’Ambrosio, M., Guccini, I., Pasquini, E., Varesi, A., Valdata, A., Mosole, S., Revandkar, A., Attanasio, G., Rinaldi, A., Rinaldi, A., Bolis, M., Cippà, P., & Alimonti, A. (2022). Single-cell transcriptomics identifies Mcl-1 as a target for senolytic therapy in cancer. Nature Communications. https://doi.org/10.1038/s41467-022-29824-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.